TH111703A - Minerocortisoid receptor antagonist and method of use - Google Patents
Minerocortisoid receptor antagonist and method of useInfo
- Publication number
- TH111703A TH111703A TH801006214A TH0801006214A TH111703A TH 111703 A TH111703 A TH 111703A TH 801006214 A TH801006214 A TH 801006214A TH 0801006214 A TH0801006214 A TH 0801006214A TH 111703 A TH111703 A TH 111703A
- Authority
- TH
- Thailand
- Prior art keywords
- formula
- compound
- salt
- minerocortisoid
- receptor antagonist
- Prior art date
Links
- 239000002464 receptor antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 6
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 239000011780 sodium chloride Substances 0.000 claims abstract 4
- 206010007559 Cardiac failure congestive Diseases 0.000 claims abstract 2
- 208000007342 Diabetic Nephropathy Diseases 0.000 claims abstract 2
- 206010061835 Diabetic nephropathy Diseases 0.000 claims abstract 2
- 206010020772 Hypertension Diseases 0.000 claims abstract 2
- 206010029164 Nephrotic syndrome Diseases 0.000 claims abstract 2
- 108009000551 Nephrotic syndrome Proteins 0.000 claims abstract 2
- 239000000969 carrier Substances 0.000 claims abstract 2
- 230000001684 chronic Effects 0.000 claims abstract 2
- 201000006233 congestive heart failure Diseases 0.000 claims abstract 2
- 239000003085 diluting agent Substances 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 239000000546 pharmaceutic aid Substances 0.000 claims abstract 2
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 2
- 230000000144 pharmacologic effect Effects 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
Abstract
DC60 (19/02/52) การประดิษฐ์นี้ให้สารประกอบของสูตร (I) (สูตรเคมี) สูตร (I) หรือเกลือของมันที่เป็นที่ยอมรับเชิงเภสัชวิทยา; องค์ประกอบทางเภสัชกรรม ซึ่งประกอบรวมด้วย สารประกอบของสูตร (I) ผสมผสานกันกับสารตัวพา, สารทำเจือจาง, หรือส่วนเติมเนื้อยาที่เหมาะสม; และวิธีสำหรับการบำบัดความผิดปกติทางสรีระวิทยา, โดยเฉพาะหัวใจล้มเหลวจากเลือดคั่ง, ความดัน สูง, โรคไตเหตุเบาหวาน, หรือโรคไตเรื้อรัง, ซึ่งประกอบรวมด้วยการให้สารประกอบของสูตร (I), หรือเกลือของมันที่เป็นที่ยอมรับเชิงเภสัชวิทยา : สิทธิบัตรยา DC60 (19/02/52) This invention provides a compound of formula (I) (chemical formula), formula (I) or its salt that is pharmacologically acceptable; Pharmaceutical components Which includes Formula (I) compound combined with a carrier, diluent, or appropriate drug additive; And methods for the treatment of physiological disorders, especially congestive heart failure, hypertension, diabetic nephropathy, or chronic nephrotic syndrome, including the administration of a compound of formula (I), or salt. Its Pharmacological Acceptance: Drug Patents
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH111703A true TH111703A (en) | 2012-01-30 |
| TH111703B TH111703B (en) | 2012-01-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY150474A (en) | 6h-dibenzo [b,e] oxepine derived nonsteroidal mineralocorticoid receptor antogonists | |
| CL2011003347A1 (en) | Pharmaceutical composition comprising a conjugate, corresponding to hydrocodone benzoate; and use in the treatment of a disease, disorder or condition mediated by the binding of an opioid to opioid receptors. | |
| MX2009007180A (en) | Piperidine gpcr agonists. | |
| WO2007003961A3 (en) | Gpcr agonists | |
| HK1158192A1 (en) | Piperidine gpcr agonists | |
| NO20084403L (en) | Cyclohexylpyrazole-lactam derivatives as inhibitors of II-beta-hydroxysteroid dehydrogenase I | |
| CY1112483T1 (en) | Piperidine GPCR agonists | |
| DE602005023197D1 (en) | -MUSCARINREZEPTORS | |
| GB0812642D0 (en) | Compounds | |
| MX2011009506A (en) | Mineralocorticoid receptor antagonist and methods of use. | |
| TH111703A (en) | Minerocortisoid receptor antagonist and method of use | |
| WO2008056059A3 (en) | 4-azasterol derivatives, methods for the synthesis thereof and use of same as drugs | |
| JO2827B1 (en) | Mineralocorticoid Receptor Antagonists And Methods Of Use | |
| TH114428A (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
| TH118890A (en) | Useful imidazopiridazine carbonitrile as a kinase inhibitor. | |
| TH146086A (en) | Thyinopirimidenones replaced by hydroxyl as an antagonist of the receptor-1. Of hormones that make melanin concentrated | |
| TH102414A (en) | Tetrahydropane [b] indole compounds. It is a modified androgen receptor. | |
| TH134369A (en) | A new component for the treatment of metabolic disorders | |
| WO2011080500A3 (en) | New pharmaceutical dosage form for the treatment of gastric acid-related disorders | |
| TH109186A (en) | A new process for the synthesis of Ivaradine and its salts, the addition of it with a pharmaceutical acceptable acid. | |
| TH80299B (en) | The use of PPAR agonist for the treatment of congestive heart failure | |
| TH114428B (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
| TH93948B (en) | Diphenylacetinone, which has been replaced by a new type of piperazine-1-sulfonic acid, has improved pharmacological properties. | |
| TH104134A (en) | 3-carboxypropyl-aminotetralene derivatives And related compounds, which are muopoiide receptors, antagonists. | |
| TH156762A (en) | Inhibition of IL 17 and IFN-gamma for the treatment of autoimmune inflammation. |